根据提供的文献内容，我将提取并整理出所需的信息，并以JSON格式呈现。以下是提取和标准化后的信息：

```json
{
    "Variants Include": [
        {
            "Gene": "LRRK2",
            "variants": [
                {
                    "HGVS": "NM_198578.2:c.6055G>A",
                    "cDNA Change": {
                        "transcript": "NM_198578.2",
                        "ref": "G",
                        "alt": "A",
                        "position": "6055"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "S",
                        "position": "2019"
                    },
                    "Description in input context": "c.6055G>A (p.G2019S)"
                },
                {
                    "HGVS": "NM_198578.2:c.6056A>T",
                    "cDNA Change": {
                        "transcript": "NM_198578.2",
                        "ref": "A",
                        "alt": "T",
                        "position": "6056"
                    },
                    "Protein Change": {
                        "ref": "I",
                        "alt": "T",
                        "position": "2020"
                    },
                    "Description in input context": "c.6056A>T (p.I2020T)"
                },
                {
                    "HGVS": "NM_198578.2:c.4322G>C",
                    "cDNA Change": {
                        "transcript": "NM_198578.2",
                        "ref": "G",
                        "alt": "C",
                        "position": "4322"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "C",
                        "position": "1441"
                    },
                    "Description in input context": "c.4322G>C (p.R1441C)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005072"
    },
    "Experiment Method": [
        {
            "Assay Method": "Kinase Activity Assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK293",
                "Description": "HEK293 cells were transfected with plasmid DNA encoding LRRK2 variants and used for kinase assays."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_198578.2:c.6055G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "LRRK2 G2019S showed a 3–4-fold increase in MKK6 phosphorylation compared with wild-type LRRK2."
                },
                {
                    "Variant": "NM_198578.2:c.6056A>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "LRRK2 I2020T showed a 1.5-fold increase in MKK6 phosphorylation compared with wild-type LRRK2."
                },
                {
                    "Variant": "NM_198578.2:c.4322G>C",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "LRRK2 R1441C showed no significant alteration in kinase activity."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "At least four independent data points were used for each mutant."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in multiple replicates."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type LRRK2 was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Kinase dead LRRK2 K1906M was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "2"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA/Tukey’s post-hoc test was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Phosphorylation levels were normalized to the average of LRRK2 wild-type phosphorylation which was set as 100%.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Significant increase in phosphorylation levels above 100%.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释说明：
1. **Variants Include**：列出了与帕金森病相关的LRRK2基因变异体，包括HGVS命名法、cDNA变化和蛋白质变化。
2. **Described Disease**：描述了文献中研究的疾病为帕金森病，并从MONDO数据库中检索到对应的术语MONDO:0005072。
3. **Experiment Method**：详细描述了实验方法（激酶活性测定），包括使用的材料来源（HEK293细胞）、读出类型（定量）、结果描述（每个变异体的具体实验结果）、生物学和技术重复、对照设置、统计分析方法以及正常和异常结果的阈值。
4. **Readout description**：对于每种实验方法，列出了所有变异体的结果描述，确保每个变异体的实验结果都清晰明了。

通过这种方式，我们可以确保提取的信息准确且符合科学文献的标准。